Position in SNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$557,201
+$129,736 QoQ
Shares Held
11,565
+31.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SkyView Investment Advisors, LLC holds $5,693,586 across 8 Drug Manufacturers - General names. SNY ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,141 | $1,408,348 | |
| 2 | PFE |
Pfizer Inc
|
44,796 | $1,257,871 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
5,942 | $828,136 | |
| 4 | NVO |
Novo Nordisk A S
|
19,010 | $698,617 | |
| 5 | SNY |
Sanofi
This page
|
11,565 | $557,201 | |
| 6 | ABBV |
AbbVie Inc.
|
1,839 | $399,964 | |
| 7 | AMGN |
Amgen Inc
|
789 | $277,609 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,210 | $265,840 |
All Filings in SNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $557,201 | 11,565 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $427,465 | 8,821 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $416,351 | 8,821 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $426,142 | 8,821 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $489,212 | 8,821 | Shares | Sole | 2025-08-15 | |
| No filing history on record for this holder in this stock. | ||||||